ArticleJournal of breast cancer2012

The Predictive Value of Serum HER2/neu for Response to Anthracycline-Based and Trastuzumab-Based Neoadjuvant Chemotherapy.

Jung Sun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.